Modulation of cardiomyocyte electrical properties using regulated bone morphogenetic protein-2 expression

Tissue Engineering - Part A

Volumn 14, Issue 12, 2008, Pages 1969-1988

  Diaz Sanchez Bustamante, Carlota ^a   Frey, Urs ^a   Kelm, Jens M ^b   Hierlemann, Andreas ^a   Fussenegger, Martin ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; BONE; CHARGE COUPLED DEVICES; ELECTRIC PROPERTIES; ELECTRON ENERGY LEVELS; GENE EXPRESSION; LOGIC CIRCUITS; METALLIC COMPOUNDS; MODULATION; MONOLAYERS; MOS DEVICES; PROTEINS; SEMICONDUCTOR MATERIALS;

BONE MORPHOGENETIC PROTEIN-2; CARDIAC RHYTHMS; CARDIAC TISSUES; CARDIOMYOCYTE; CARDIOMYOCYTES; CELL LOSSES; COMPLEMENTARY METAL OXIDE SEMICONDUCTORS; ELECTRICAL ACTIVITIES; ELECTRICAL PROPERTIES; ELECTROPHYSIOLOGICAL ACTIVITIES; FUNCTION ANALYSIS; HEART TISSUES; HIGH DENSITIES; LENTIVIRAL VECTORS; LOCAL REGULATIONS; MICRO TISSUES; MICROELECTRODE ARRAYS; NEONATAL RAT CARDIOMYOCYTES; PRISTINAMYCIN; REGION OF INTERESTS; TRANSGENES; TRANSGENIC;

ELECTROPHYSIOLOGY;

ACETALDEHYDE; BONE MORPHOGENETIC PROTEIN 2; LENTIVIRUS VECTOR; PRISTINAMYCIN;

AMPLITUDE MODULATION; ANIMAL TISSUE; ARTICLE; FREQUENCY MODULATION; GENE EXPRESSION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE CULTURE; TISSUE ENGINEERING;

LENTIVIRUS; RATTUS;

EID: 56549098709     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0302     Document Type: Article

References (90)

1. Cohn, J.N., Bristow, M.R., Chien, K.R., Colucci, W.S., Frazier, O.H., Leinwand, L.A., Lorell, B.H., Moss, A.J., Sonnenblick, E.H., Walsh, R.A., Mockrin, S.C. and Reinlib, L. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95, 766, 1997.
2. Lehmann-Horn, F. and Jurkat-Rott, K. Voltage-gated ion channels and hereditary disease. Physiolog Rev 79, 1317, 1999.
3. Keating, M.T. and Sanguinetti, M.C. Molecular genetic insights into cardiovascular disease. Science 272, 681, 1996.
4. Gambit, S. New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias(1). Cardiovasc Res 52, 345, 2001.
5. Priori, S.G. and Napolitano, C. Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies. Circulation 113, 1130, 2006.
6. Chien, K. Making a play at regrowing hearts. The Scientist 20, 88, 2006.
7. Kehat, I., Khimovich, L., Caspi, O., Gepstein, A., Shofti, R., Arbel, G., Huber, I., Satin, J., Itskovitz-Eldor, J. and Gepstein, L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22, 1282, 2004.
8. Rubart, M. and Field, L.J. Cardiac regeneration: repopulating the heart. Annu Rev Physiol 68, 29, 2006.
9. Rubart, M., Pasumarthi, K.B., Nakajima, H., Soonpaa, M.H., Nakajima, H.O. and Field, L.J. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res 92, 1217, 2003.
10. Stett, A., Egert, U., Guenther, E., Hofmann, F., Meyer, T., Nisch, W. and Haemmerle, H. Biological application of microelectrode arrays in drug discovery and basic research. Analyt Bioanalyt Chem 377, 486, 2003.
11. Atherton, B.T., Meyer, D.M. and Simpson, D.G. Assembly and remodelling of myofibrils and intercalated discs in cultured neonatal rat heart cells. J Cell Sci 86, 233, 1986.
12. Chlopcikova, S., Psotova, J. and Miketova, P. Neonatal rat cardiomyocytes - a model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 145, 49, 2001.
13. Galaris, D., Hoijer, B. and Rydstrom, J. Improved methods for automatic monitoring of contracting heart cells in culture. J Biochem Biophys Meth 2, 213, 1980.
14. Harary, I. and Farley, B. In vitro studies on single beating rat heart cells. I. Growth and organization. Exp Cell Res 29, 451, 1963.
15. Harary, I. and Farley, B. In vitro studies on single beating rat heart cells. II. Intercellular communication. Exp Cell Res 29, 466, 1963.
16. Datwyler, D.A., Magyar, J.P., Busceti, V., Hirschy, A., Perriard, J.C., Bailey, J.E. and Eppenberger, H.M. Recombinant Sindbis virus allows expression and precise targeting of proteins of the contractile apparatus in cultured cardiomyocytes. Basic Res Cardiol 96, 630, 2001.
17. Sakoda, T., Kasahara, N., Hamamori, Y. and Kedes, L. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J Molec Cell Cardiol 31, 2037, 1999.
18. Mitta, B., Rimann, M., Ehrengruber, M.U., Ehrbar, M., Djonov, V., Kelm, J. and Fussenegger, M. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res 30, e113, 2002.
19. Zhao, J., Pettigrew, G.J., Thomas, J., Vandenberg, J.I., Delriviere, L., Bolton, E.M., Carmichael, A., Martin, J.L., Marber, M.S. and Lever, A.M. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol 97, 348, 2002.
20. Mitta, B., Weber, C.C., Rimann, M. and Fussenegger, M. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression. Nucleic Acids Res 32, e106, 2004.
21. Hartenbach, S. and Fussenegger, M. Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors. J Biotechnol 120, 83, 2005.
22. Mitta, B., Weber, C.C. and Fussenegger, M. In vivo transduction of HIV-1-derived lentiviral particles engineered for macrolide-adjustable transgene expression. J Gene Med 7, 1400, 2005.
23. Vogel, R., Amar, L., Thi, A.D., Saillour, P. and Mallet, J. A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. Hum Gene Ther 15, 157, 2004.
24. Regulier, E., Trottier, Y., Perrin, V., Aebischer, P. and Deglon, N. Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. Hum Molec Genet 12, 2827, 2003.
25. Vigna, E., Cavalieri, S., Ailles, L., Geuna, M., Loew, R., Bujard, H. and Naldini, L. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol Ther 5, 252, 2002.
26. Koponen, J.K., Kankkonen, H., Kannasto, J., Wirth, T., Hillen, W., Bujard, H. and Yla-Herttuala, S. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther 10, 459, 2003.
27. Johansen, J., Rosenblad, C., Andsberg, K., Moller, A., Lundberg, C., Bjorlund, A. and Johansen, T.E. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS. Gene Ther 9, 1291, 2002.
28. Fussenegger, M., Schlatter, S., Datwyler, D., Mazur, X. and Bailey, J.E. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 16, 468, 1998.
29. Fux, C., Langer, D. and Fussenegger, M. Dual-regulated myoD- and msx1-based interventions in C2C12-derived cells enable precise myogenic/osteogenic/adipogenic lineage control. J Gene Med 6, 1159, 2004.
30. Fux, C., Mitta, B., Kramer, B.P. and Fussenegger, M. Dual-regulated expression of C/EBP-alpha and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts. Nucleic Acids Res 32, e1, 2004.
31. Fussenegger, M. The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog 17, 1, 2001.
32. Kelm, J.M., Kramer, B.P., Gonzalez-Nicolini, V., Ley, B. and Fussenegger, M. Synergies of microtissue design, viral transduction and adjustable transgene expression for regenerative medicine. Biotechnol Applied Biochem 39, 3, 2004.
33. Weber, W. and Fussenegger, M. Approaches for trigger-inducible viral transgene regulation in gene-based tissue engineering. Curr Opin Biotechnol 15, 383, 2004.
34. Weber, W. and Fussenegger, M. Novel gene switches. Handb Exp Pharmacol 73, 2007.
35. Fussenegger, M., Morris, R.P., Fux, C., Rimann, M., von Stockar, B., Thompson, C.J. and Bailey, J.E. Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 18, 1203, 2000.
36. Weber, W., Rimann, M., Spielmann, M., Keller, B., Daoud-El Baba, M., Aubel, D., Weber, C.C. and Fussenegger, M. Gas-inducible transgene expression in mammalian cells and mice. Nat Biotechnol 22, 1440, 2004.
37. Abbott, A. Cell culture: biology's new dimension. Nature 424, 870, 2003.
38. Zhang, S. Beyond the Petri dish. Nat Biotechnol 22, 151, 2004.
39. Heer, F., Hafizovic, S., Ugniwenko, T., Frey, U., Franks, W., Perriard, E., Perriard, J.C., Blau, A., Ziegler, C. and Hierlemann, A. Single-chip microelectronic system to interface with living cells. Biosens Bioelectron 22, 2546, 2007.
40. Frey, U., Heer, F., Pedron, R., Greve, F., Hafizovic, S., Kirstein, K.-U. and Hierlemann, A. 11'000 electrode-, 126 channel-CMOS microelectrode array for electrogenic cells. IEEE 20th International Conference on Micro Electro Mechanical Systems, MEMS, Kobe, Japan, 2007.
41. Frey, U., Heer, F., Pedron, R., Hafizovic, S., Greve, F., Sedivy, J., Kirstein, K.-U. and Hierlemann, A. An 11k-electrode 126-channel highdensity microelectrode array to interact with electrogenic cells. Proceedings of the IEEE ISSCC 2007, San Francisco, CA, 2007.
42. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M. and Wang, E.A. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528, 1988.
43. Hogan, B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10, 1580, 1996.
44. Ghosh-Choudhury, N., Abboud, S.L., Chandrasekar, B. and Ghosh Choudhury, G. BMP-2 regulates cardiomyocyte contractility in a phosphatidylinositol 3 kinase-dependent manner. FEBS Lett 544, 181, 2003.
45. Wang, Y.X., Qian, L.X., Liu, D., Yao, L.L., Jiang, Q., Yu, Z., Gui, Y.H., Zhong, T.P. and Song, H.Y. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 74, 290, 2007.
46. Ghosh-Choudhury, N., Abboud, S.L., Mahimainathan, L., Chandrasekar, B. and Choudhury, G.G. Phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells. J Biol Chem 278, 21998, 2003.
47. Crackower, M.A., Oudit, G.Y., Kozieradzki, I., Sarao, R., Sun, H., Sasaki, T., Hirsch, E., Suzuki, A., Shioi, T., Irie-Sasaki, J., Sah, R., Cheng, H.Y., Rybin, V.O., Lembo, G., Fratta, L., Oliveira-dos-Santos, A.J., Benovic, J.L., Kahn, C.R., Izumo, S., Steinberg, S.F., Wymann, M.P., Backx, P.H. and Penninger, J.M. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110, 737, 2002.
48. Zhang, H. and Bradley, A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122, 2977, 1996.
49. Monzen, K., Nagai, R. and Komuro, I. A role for bone morphogenetic protein signaling in cardiomyocyte differentiation. Trends Cardiovasc Med 12, 263, 2002.
50. Abdelwahid, E., Rice, D., Pelliniemi, L.J. and Jokinen, E. Overlapping and differential localization of Bmp-2, Bmp-4, Msx-2 and apoptosis in the endocardial cushion and adjacent tissues of the developing mouse heart. Cell Tissue Res 305, 67, 2001.
51. Masaki, M., Izumi, M., Oshima, Y., Nakaoka, Y., Kuroda, T., Kimura, R., Sugiyama, S., Terai, K., Kitakaze, M., Yamauchi-Takihara, K., Kawase, I. and Hirota, H. Smad1 protects cardiomyocytes from ischemia-reperfusion injury. Circulation 111, 2752, 2005.
52. Izumi, M., Fujio, Y., Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Oshima, Y., Nakaoka, Y., Kishimoto, T., Yamauchi-Takihara, K. and Hirota, H. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway. J Biol Chem 276, 31133, 2001.
53. Frey, U., Sanchez-Bustamante, C.D., Ugniwenko, T., Heer, F., Sedivy, J., Hafizovic, S., Roscic, B., Fussenegger, M., Blau, A., Egert, U. and Hierlemann, A. Cell recordings with a CMOS high-density microelectrode array. Proc. of the 29th International IEEEEMBSConference, Lyon, France, 167, 2007.
54. Auerbach, D., Bantle, S., Keller, S., Hinderling, V., Leu, M., Ehler, E. and Perriard, J.C. Different domains of the M-band protein myomesin are involved in myosin binding and M-band targeting. Mol Biol Cell 10, 1297, 1999.
55. Mitta, B., Rimann, M. and Fussenegger, M. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles. Metabol Eng 7, 426, 2005.
56. Kelm, J.M., Timmins, N.E., Brown, C.J., Fussenegger, M. and Nielsen, L.K. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83, 173, 2003.
57. Sanchez-Bustamante, C.D., Kelm, J.M., Mitta, B. and Fussenegger, M. Heterologous protein production capacity of mammalian cells cultivated as monolayers and microtissues. Biotechnol Bioeng 93, 169, 2006.
58. Quiroga, R.Q., Nadasdy, Z. and Ben-Shaul, Y. Unsupervised spike detection and sorting with wavelets and superparamagnetic clustering. Neural Comput 16, 1661, 2004.
59. Halbach, M., Egert, U., Hescheler, J. and Banach, K. Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem 13, 271, 2003.
60. Spach, M.S., Miller, W.T., 3rd, Miller-Jones, E., Warren, R.B. and Barr, R.C. Extracellular potentials related to intracellular action potentials during impulse conduction in anisotropic canine cardiac muscle. Circ Res 45, 188, 1979.
61. Hescheler, J., Halbach, M., Egert, U., Lu, Z.J., Bohlen, H., Fleischmann, B.K. and Reppel, M. Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. J Electrocardiol 37 Suppl, 110, 2004.
62. Xiao, R.P., Zhu, W., Zheng, M., Cao, C., Zhang, Y., Lakatta, E.G. and Han, Q. Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 27, 330, 2006.
63. Fedida, D., Braun, A.P. and Giles, W.R. Alpha 1-adrenoceptors reduce background K+ current in rabbit ventricular myocytes. J Physiol 441, 673, 1991.
64. Van Wagoner, D.R., Kirian, M. and Lamorgese, M. Phenylephrine suppresses outward K+ currents in rat atrial myocytes. Am J Physiol 271, H937, 1996.
65. Xiao, R.P., Zhu, W., Zheng, M., Chakir, K., Bond, R., Lakatta, E.G. and Cheng, H. Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 25, 358, 2004.
66. Xiao, Y.F., Ke, Q., Wang, S.Y., Yang, Y., Chen, Y., Wang, G.K., Morgan, J.P., Cox, B. and Leaf, A. Electrophysiologic properties of lidocaine, cocaine, and n-3 fatty-acids block of cardiac Na+ channels. Eur J Pharmacol 485, 31, 2004.
67. Ridley, J.M., Milnes, J.T., Zhang, Y.H., Witchel, H.J. and Hancox, J.C. Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine. J Physiol 549, 667, 2003.
68. Weber, W., Kramer, B.P., Fux, C., Keller, B. and Fussenegger, M. Novel promoter/transactivator configurations for macrolide- and streptogramin- responsive transgene expression in mammalian cells. J Gene Med 4, 676, 2002.
69. Kelm, J.M., Ehler, E., Nielsen, L.K., Schlatter, S., Perriard, J.C. and Fussenegger, M. Design of artificial myocardial microtissues. Tissue Eng 10, 201, 2004.
70. Kusumoto, F.M. and Goldschlager, N. Cardiac pacing. N Engl J Med 334, 89, 1996.
71. Hennekens, C.H. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 97, 1095, 1998.
72. Strauer, B.E., Brehm, M., Zeus, T., Kostering, M., Hernandez, A., Sorg, R.V., Kogler, G. and Wernet, P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913, 2002.
73. SoRelle, R. Myoblast transplant to heart attempted. Circulation 102, E9030, 2000.
74. Robinson, R.B., Brink, P.R., Cohen, I.S. and Rosen, M.R. I(f ) and the biological pacemaker. Pharmacol Res 53, 407, 2006.
75. Rosen, M.R., Brink, P.R., Cohen, I.S. and Robinson, R.B. Genes, stem cells and biological pacemakers. Cardiovasc Res 64, 12, 2004.
76. Dowell, J.D., Rubart, M., Pasumarthi, K.B., Soonpaa, M.H. and Field, L.J. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58, 336, 2003.
77. Brodie, C. and Sampson, S.R. Effects of ethanol on voltage-sensitive Na-channels in cultured skeletal muscle: upregulation as a result of chronic treatment. J Pharmacol Exp Ther 255, 1195, 1990.
78. van Wijk, B., Moorman, A.F. and van den Hoff, M.J. Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 74, 244, 2007.
79. Kleber, A.G. and Rudy, Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiolog Rev 84, 431, 2004.
80. Rohr, S., Kucera, J.P. and Kleber, A.G. Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ Res 83, 781, 1998.
81. Kleber, A.G. The shape of the electrical action-potential upstroke: a new aspect from optical measurements on the surface of the heart. Circ Res 97, 204, 2005.
82. Capogrossi, M.C., Kachadorian, W.A., Gambassi, G., Spurgeon, H.A. and Lakatta, E.G. Ca2+ dependence of alpha-adrenergic effects on the contractile properties and Ca2+ homeostasis of cardiac myocytes. Circ Res 69, 540, 1991.
83. Kamp, T.J. and Hell, J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87, 1095, 2000.
84. Allen, D.L., Weber, J.N., Sycuro, L.K. and Leinwand, L.A. Myocyte enhancer factor-2 and serum response factor binding elements regulate fast myosin heavy chain transcription in vivo. J Biol Chem 280, 17126, 2005.
85. Molkentin, J.D. and Markham, B.E. Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo. J Biol Chem 268, 19512, 1993.
86. Morkin, E. Control of cardiac myosin heavy chain gene expression. Microsc Res Tech 50, 522, 2000.
87. Swynghedauw, B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiolog Rev 66, 710, 1986.
88. Miyata, S., Minobe, W., Bristow, M.R. and Leinwand, L.A. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 86, 386, 2000.
89. Kunz-Schughart, L.A., Freyer, J.P., Hofstaedter, F. and Ebner, R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 9, 273, 2004.
90. Kelm, J.M., Djonov, V., Hoerstrup, S.P., Guenter, C.I., Ittner, L.M., Greve, F., Hierlemann, A., Sanchez-Bustamante, C.D., Perriard, J.C., Ehler, E. and Fussenegger, M. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng 12, 2541, 2006.